Is Terbinafine (Terbinafine) 250mg QD (once daily) for 90 days a suitable treatment for a 34-year-old male patient with toenail fungal infection and a partially lifted right big toenail?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Terbinafine 250mg Daily for 90 Days for Toenail Fungal Infection

Terbinafine 250mg daily for 90 days (12-16 weeks) is the first-line treatment for toenail fungal infection in this 34-year-old male patient with a partially lifted right big toenail. 1, 2

Treatment Rationale and Efficacy

  • Terbinafine is considered the first-line treatment for dermatophyte onychomycosis and is generally preferred over itraconazole due to its superior efficacy both in vitro and in vivo 1
  • The British Association of Dermatologists recommends terbinafine 250mg daily for 12-16 weeks (84-112 days) for toenail infections, which aligns with the proposed 90-day treatment course 2
  • Terbinafine is fungicidal against dermatophytes with very low minimum inhibitory concentrations, making it highly effective for toenail fungal infections 2
  • Clinical studies have demonstrated mycological cure rates of 70-80% for toenail infections with terbinafine treatment 1
  • Terbinafine has shown higher cure rates compared to itraconazole in comparative trials (73% vs 45.8% at 48 weeks) 3

Considerations for the Partially Lifted Toenail

  • The partially lifted right big toenail (onycholysis) is a common presentation in onychomycosis and can make treatment more challenging 1
  • Re-evaluation at 6 weeks as planned is appropriate to assess if toenail extraction is needed 2
  • In cases with significant onycholysis or suspected subungual dermatophytoma (dense fungal mass), partial nail removal may be necessary to improve treatment outcomes 1
  • The British Association of Dermatologists guidelines note that "in cases of treatment failure, partial nail removal is indicated" particularly for the big toenail 1

Monitoring and Safety Considerations

  • Baseline liver function tests are recommended before starting treatment, particularly in patients with pre-existing liver disease or history of hepatotoxic medication use 1, 4
  • Common side effects include headache (most common), gastrointestinal upset, taste disturbance, and rarely skin reactions 4
  • Terbinafine is contraindicated in patients with active or chronic liver disease 4
  • Liver failure, though rare, has been reported with oral terbinafine use; discontinue treatment if liver injury develops 4

Prevention of Recurrence

  • Advise the patient to:
    • Keep nails short and clean 1
    • Wear protective footwear in public areas like gyms, hotel rooms, and swimming pools 1
    • Use absorbent cotton socks and antifungal powders in shoes 1
    • Consider discarding old footwear or treating it with antifungal powders 1

Follow-up Recommendations

  • The planned 6-week follow-up is appropriate to reassess the need for toenail extraction 2
  • Complete nail regrowth may take up to 12-18 months due to the slow growth of toenails 1
  • Treatment success should be evaluated based on both clinical improvement and mycological cure 1
  • If there is no improvement at follow-up, consider:
    • Confirming the diagnosis with mycological testing if not already done 1
    • Evaluating for potential dermatophytoma that may require nail debridement 1
    • Assessing treatment compliance and absorption issues 1

Treatment Alternatives

  • If terbinafine is contraindicated or not tolerated, itraconazole is the next best alternative (200mg daily for 12 weeks continuously, or pulse therapy at 400mg daily for 1 week per month for 3 pulses) 1
  • Topical treatments alone have limited efficacy for toenail infections, particularly with significant nail involvement 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Terbinafine Treatment for Onychomycosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.